Home Sitemap Contact us Accessibility Statement Top of the page
  • Ovaleap®▼(follitropin alfa)  from Teva


    (follitropin alfa)*

Prescribing Ovaleap®

Ovaleap® (follitropin alfa) : 300IU/0.5mL, 450IU/0.75mL and 900IU/1.5mL

What is Ovaleap®?

Ovaleap® contains the active substance follitropin alfa, which is almost identical to a natural hormone produced by your body called “follicle-stimulating hormone” (FSH). FSH is a gonadotropin, a type of hormone that plays an important role in human fertility and reproduction. In women, FSH is needed for the growth and development of the sacs (follicles) in the ovaries that contain the egg cells. In men, FSH is needed for the production of sperm.

What is Ovaleap® used for?

In adult women, Ovaleap® is used:

  • To help ovulation (release of a mature egg cell from the follicle) in women that cannot ovulate and that have not responded to treatment with a medicine called “clomifene citrate”.
  • To help follicles develop in women undergoing assisted reproductive technology procedures (procedures that may help you to become pregnant) such as “in vitro fertilisation”, “gamete intra-fallopian transfer” or “zygote intra-fallopian transfer”.
  • In combination with a medicine called “lutropin alfa” (a version of another gonadotropin, “luteinising hormone” or LH) to help ovulation in women that are not ovulating because their body is producing too little FSH and LH.

In adult men, Ovaleap® is used:

  • In combination with a medicine called “human chorionic gonadotropin” (hCG) to help produce sperm in men that are infertile due to low levels of certain hormones.

About Ovaleap®

What Ovaleap® looks like and contents of the pack

Ovaleap® is a clear and colourless solution for injection.

Ovaleap® is available in the following pack sizes:

  • Ovaleap® 300 IU/0.5 mL is available in packs containing 1 cartridge and 10 injection needles.
  • Ovaleap® 450 IU/0.75 mL is available in packs containing 1 cartridge and 10 injection needles.
  • Ovaleap® 900 IU/1.5 mL is available in packs containing 1 cartridge and 20 injection needles. 

This medicine is given using the Ovaleap Pen®. The Ovaleap Pen® is a device (a “pen”) used for giving injections into the tissue just under the skin. Your doctor may suggest that you learn how to inject yourself with this medicine. Your doctor or nurse will give you instructions on how to do this and you can also find instructions in the separate instructions for use booklet, provided with the pen. Ovaleap® solution for injection in cartridges has been developed for use with the Ovaleap Pen® only.

Please speak to you doctor or nurse if you have any concerns with injecting Ovaleap®.

How to use the Ovaleap Pen® - 300/450IU Dose

Download Video: MP4, WebM Ogv

How to use the Ovaleap Pen® - 900IU Dose

Download Video: MP4, WebM Ogv

Marketing Authorisation

Teva B.V.
Swensweg 5
2031GA Haarlem
The Netherlands

Marketing Authorisation Number(s)

  • EU/1/13/871/001-003

Resources for Ovaleap®

You can ask a question, or report a side effect to Teva.

Ask a Question Report Suspected Side Effect
Medicine supporting documentation for Ovaleap®

1 Ovaleap® (follitropin alfa) Summary of Product Characteristics.

* This medicine is subject to additional monitoring to allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects.

Teva UK Limited

This page is for patients who have been prescribed Ovaleap®▼ (follitropin alfa). Please confirm if you have been prescribed Ovaleap®: